103
Views
6
CrossRef citations to date
0
Altmetric
Special Focus: Pediatric Infections - Review

Recently tested strategies to reduce nosocomial infections in the neonatal intensive care unit

&
Pages 235-242 | Published online: 10 Jan 2014

References

  • Efird MM, Rojas MA, Lozano JM et al. Epidemiology of nosocomial infections in selected neonatal intensive care units in Colombia, South America. J. Perinatol.25(8), 531–536 (2005).
  • Nagata E, Brito AS, Matsuo T. Nosocomial infections in a neonatal intensive care unit: incidence and risk factors. Am. J. Infect. Control30(1), 26–31 (2002).
  • Pessoa-Silva CL, Richtmann R, Calil R et al. Healthcare-associated infections among neonates in Brazil. Infect. Control Hosp. Epidemiol.25(9), 772–777 (2004).
  • Jeong IS, Jeong JS, Choi EO. Nosocomial infection in a newborn intensive care unit (NICU), South Korea. BMC Infect. Dis.6, 103 (2006).
  • Couto RC, Pedrosa TM, Tofani Cde P, Pedroso ER. Risk factors for nosocomial infection in a neonatal intensive care unit. Infect. Control Hosp. Epidemiol.27(6), 571–575 (2006).
  • Schulman J, Stricof RL, Stevens TP et al. Development of a statewide collaborative to decrease NICU central line-associated bloodstream infections. J. Perinatol.29(9), 591–599 (2009).
  • Aziz K, McMillan DD, Andrews W et al. Variations in rates of nosocomial infection among Canadian neonatal intensive care units may be practice-related. BMC Pediatr.5, 22 (2005).
  • Perlman SE, Saiman L, Larson EL. Risk factors for late-onset health care-associated bloodstream infections in patients in neonatal intensive care units. Am. J. Infect. Control35(3), 177–182 (2007).
  • Urrea M, Iriondo M, Thio M et al. A prospective incidence study of nosocomial infections in a neonatal care unit. Am. J. Infect. Control31(8), 505–507 (2003).
  • van der Zwet WC, Kaiser AM, van Elburg RM et al. Nosocomial infections in a Dutch neonatal intensive care unit: surveillance study with definitions for infection specifically adapted for neonates. J. Hosp. Infect.61(4), 300–311 (2005).
  • Couto RC, Carvalho EA, Pedrosa TM, Pedroso ER, Neto MC, Biscione FM. A 10-year prospective surveillance of nosocomial infections in neonatal intensive care units. Am. J. Infect. Control35(3), 183–189 (2007).
  • Haas J, Larson E, Ross B, See B, Saiman L. Epidemiology and diagnosis of hospital-acquired conjunctivitis among neonatal intensive care unit patients. Pediatr. Infect. Dis. J.24(7), 586–589 (2005).
  • Stoll BJ, Hansen N, Fanaroff AA et al. To tap or not to tap: high likelihood of meningitis without sepsis among very low birth weight infants. Pediatrics113(5), 1181–1186 (2004).
  • Makhoul IR, Sujov P, Smolkin T, Lusky A, Reichman B. Epidemiological, clinical, and microbiological characteristics of late-onset sepsis among very low birth weight infants in Israel: a national survey. Pediatrics109(1), 34–39 (2002).
  • Stoll BJ, Hansen N, Fanaroff AA et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics110(2 Pt 1), 285–291 (2002).
  • Nambiar S, Singh N. Change in epidemiology of health care-associated infections in a neonatal intensive care unit. Pediatr. Infect. Dis. J.21(9), 839–842 (2002).
  • Ronnestad A, Abrahamsen TG, Medbo S et al. Late-onset septicemia in a Norwegian national cohort of extremely premature infants receiving very early full human milk feeding. Pediatrics115(3), e269–e276 (2005).
  • Boyce JM, Pittet D. Guideline for hand hygiene in health-care settings. Recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. Society for Healthcare Epidemiology of America/Association for Professionals in Infection Control/Infectious Diseases Society of America. MMWR Recomm. Rep.51(RR-16), 1–45, quiz CE41–CE44 (2002).
  • Pessoa-Silva CL, Dharan S, Hugonnet S et al. Dynamics of bacterial hand contamination during routine neonatal care. Infect. Control Hosp. Epidemiol.25(3), 192–197 (2004).
  • Pittet D, Dharan S, Touveneau S, Sauvan V, Perneger TV. Bacterial contamination of the hands of hospital staff during routine patient care. Arch. Intern. Med.159(8), 821–826 (1999).
  • Pittet D. Improving adherence to hand hygiene practice: a multidisciplinary approach. Emerging Infect. Dis.7(2), 234–240 (2001).
  • Voss A, Widmer AF. No time for handwashing!? Handwashing versus alcoholic rub: can we afford 100% compliance? Infect. Control Hosp. Epidemiol.18(3), 205–208 (1997).
  • Brown SM, Lubimova AV, Khrustalyeva NM et al. Use of an alcohol-based hand rub and quality improvement interventions to improve hand hygiene in a Russian neonatal intensive care unit. Infect. Control Hosp. Epidemiol.24(3), 172–179 (2003).
  • Harbarth S, Pittet D, Grady L et al. Interventional study to evaluate the impact of an alcohol-based hand gel in improving hand hygiene compliance. Pediatr. Infect. Dis. J.21(6), 489–495 (2002).
  • Tenorio AR, Badri SM, Sahgal NB et al. Effectiveness of gloves in the prevention of hand carriage of vancomycin-resistant enterococcus species by health care workers after patient care. Clin. Infect. Dis.32(5), 826–829 (2001).
  • Cohen B, Saiman L, Cimiotti J, Larson E. Factors associated with hand hygiene practices in two neonatal intensive care units. Pediatr. Infect. Dis. J.22(6), 494–499 (2003).
  • Lam BC, Lee J, Lau YL. Hand hygiene practices in a neonatal intensive care unit: a multimodal intervention and impact on nosocomial infection. Pediatrics114(5), e565–e571 (2004).
  • Pessoa-Silva CL, Hugonnet S, Pfister R et al. Reduction of health care associated infection risk in neonates by successful hand hygiene promotion. Pediatrics120(2), e382–e390 (2007).
  • Pittet D, Hugonnet S, Harbarth S et al. Effectiveness of a hospital-wide programme to improve compliance with hand hygiene. Infection Control Programme. Lancet356(9238), 1307–1312 (2000).
  • Won SP, Chou HC, Hsieh WS et al. Handwashing program for the prevention of nosocomial infections in a neonatal intensive care unit. Infect. Control Hosp. Epidemiol.25(9), 742–746 (2004).
  • Palmer C, Bik EM, DiGiulio DB, Relman DA, Brown PO. Development of the human infant intestinal microbiota. PLoS Biol.5(7), e177 (2007).
  • Favier CF, Vaughan EE, De Vos WM, Akkermans AD. Molecular monitoring of succession of bacterial communities in human neonates. Appl. Environ. Microbiol.68(1), 219–226 (2002).
  • Goldmann DA, Leclair J, Macone A. Bacterial colonization of neonates admitted to an intensive care environment. J. Pediatr.93(2), 288–293 (1978).
  • Berwick DM. The science of improvement. JAMA299(10), 1182–1184 (2008).
  • Schulman J, Wirtschafter DD, Kurtin P. Neonatal intensive care unit collaboration to decrease hospital-acquired bloodstream infections: from comparative performance reports to improvement networks. Pediatr. Clin. North Am.56(4), 865–892 (2009).
  • Laffel G, Blumenthal D. The case for using industrial quality management science in health care organizations. JAMA262(20), 2869–2873 (1989).
  • Berwick DM. Developing and testing changes in delivery of care. Ann. Intern. Med.128(8), 651–656 (1998).
  • Plsek P. Innovative thinking for the improvement of medical systems. Ann. Intern. Med.131(6), 438–444 (1999).
  • Plsek PE. Quality improvement methods in clinical medicine. Pediatrics103(1 Suppl. E), 203–214 (1999).
  • Horbar JD. The Vermont Oxford Network: evidence-based quality improvement for neonatology. Pediatrics103(1 Suppl. E), 350–359 (1999).
  • Rogowski JA, Horbar JD, Plsek PE et al. Economic implications of neonatal intensive care unit collaborative quality improvement. Pediatrics107(1), 23–29 (2001).
  • Horbar JD, Rogowski J, Plsek PE et al. Collaborative quality improvement for neonatal intensive care. NIC/Q Project Investigators of the Vermont Oxford Network. Pediatrics107(1), 14–22 (2001).
  • Kilbride HW, Wirtschafter DD, Powers RJ, Sheehan MB. Implementation of evidence-based potentially better practices to decrease nosocomial infections. Pediatrics111(4 Pt 2), e519–e533 (2003).
  • Pronovost P, Needham D, Berenholtz S et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N. Engl. J. Med.355(26), 2725–2732 (2006).
  • Miller MR, Griswold M, Harris JM et al. Decreasing PICU catheter-associated bloodstream infections: NACHRI’s quality transformation efforts. Pediatrics DOI: 10.1542/peds.2009-1382 (2010) (Epub ahead of print).
  • Kacica MA, Horgan MJ, Ochoa L, Sandler R, Lepow ML, Venezia RA. Prevention of Gram-positive sepsis in neonates weighing less than 1500 grams. J. Pediatr.125(2), 253–258 (1994).
  • Spafford PS, Sinkin RA, Cox C, Reubens L, Powell KR. Prevention of central venous catheter-related coagulase-negative staphylococcal sepsis in neonates. J. Pediatr.125(2), 259–263 (1994).
  • Lee BE, Cheung PY, Robinson JL, Evanochko C, Robertson CM. Comparative study of mortality and morbidity in premature infants (birth weight, < 1,250 g) with candidemia or candidal meningitis. Clin. Infect. Dis.27(3), 559–565 (1998).
  • Feja KN, Wu F, Roberts K et al. Risk factors for candidemia in critically ill infants: a matched case–control study. J. Pediatr.147(2), 156–161 (2005).
  • Kicklighter SD, Springer SC, Cox T, Hulsey TC, Turner RB. Fluconazole for prophylaxis against Candidal rectal colonization in the very low birth weight infant. Pediatrics107(2), 293–298 (2001).
  • Kaufman D, Boyle R, Hazen KC, Patrie JT, Robinson M, Donowitz LG. Fluconazole prophylaxis against fungal colonization and infection in preterm infants. N. Engl. J. Med.345(23), 1660–1666 (2001).
  • Manzoni P, Stolfi I, Pugni L et al. A multicenter, randomized trial of prophylactic fluconazole in preterm neonates. N. Engl. J. Med.356(24), 2483–2495 (2007).
  • Bertini G, Perugi S, Dani C, Filippi L, Pratesi S, Rubaltelli FF. Fluconazole prophylaxis prevents invasive fungal infection in high-risk, very low birth weight infants. J. Pediatr.147(2), 162–165 (2005).
  • Healy CM, Campbell JR, Zaccaria E, Baker CJ. Fluconazole prophylaxis in extremely low birth weight neonates reduces invasive candidiasis mortality rates without emergence of fluconazole-resistant Candida species. Pediatrics121(4), 703–710 (2008).
  • Manzoni P, Arisio R, Mostert M et al. Prophylactic fluconazole is effective in preventing fungal colonization and fungal systemic infections in preterm neonates: a single-center, 6-year, retrospective cohort study. Pediatrics117(1), e22–e32 (2006).
  • Manzoni P, Leonessa M, Galletto P et al. Routine use of fluconazole prophylaxis in a neonatal intensive care unit does not select natively fluconazole-resistant Candida subspecies. Pediatr. Infect. Dis. J.27(8), 731–737 (2008).
  • Uko S, Soghier LM, Vega M et al. Targeted short-term fluconazole prophylaxis among very low birth weight and extremely low birth weight infants. Pediatrics117(4), 1243–1252 (2006).
  • Weitkamp JH, Ozdas A, LaFleur B, Potts AL. Fluconazole prophylaxis for prevention of invasive fungal infections in targeted highest risk preterm infants limits drug exposure. J. Perinatol.28(6), 405–411 (2008).
  • Clerihew L, Austin N, McGuire W. Prophylactic systemic antifungal agents to prevent mortality and morbidity in very low birth weight infants. Cochrane Database Syst. Rev.4, CD003850 (2007).
  • Long SS, Stevenson DK. Reducing Candida infections during neonatal intensive care: management choices, infection control, and fluconazole prophylaxis. J. Pediatr.147(2), 135–141 (2005).
  • Healy CM, Baker CJ, Zaccaria E, Campbell JR. Impact of fluconazole prophylaxis on incidence and outcome of invasive candidiasis in a neonatal intensive care unit. J. Pediatr.147(2), 166–171 (2005).
  • Kaufman D, Boyle R, Hazen KC, Patrie JT, Robinson M, Grossman LB. Twice weekly fluconazole prophylaxis for prevention of invasive Candida infection in high-risk infants of <1000 grams birth weight. J. Pediatr.147(2), 172–179 (2005).
  • Horn DL, Neofytos D, Anaissie EJ et al. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry. Clin. Infect. Dis.48(12), 1695–1703 (2009).
  • Nguyen MH, Peacock JE Jr, Morris AJ et al. The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance. Am. J. Med.100(6), 617–623 (1996).
  • Price MF, LaRocco MT, Gentry LO. Fluconazole susceptibilities of Candida species and distribution of species recovered from blood cultures over a 5-year period. Antimicrob. Agents Chemother.38(6), 1422–1424 (1994).
  • Rex JH, Rinaldi MG, Pfaller MA. Resistance of Candida species to fluconazole. Antimicrob. Agents Chemother.39(1), 1–8 (1995).
  • Hope W, Morton A, Eisen DP. Increase in prevalence of nosocomial non-Candida albicans candidaemia and the association of Candida krusei with fluconazole use. J. Hosp. Infect.50(1), 56–65 (2002).
  • Pappas PG, Kauffman CA, Andes D et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin. Infect. Dis.48(5), 503–535 (2009).

Website

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.